Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea. [electronic resource]
- Cancer chemotherapy and pharmacology Oct 2017
- 799-805 p. digital
Publication Type: Journal Article; Multicenter Study
1432-0843
10.1007/s00280-017-3421-7 doi
Adult Aged Aged, 80 and over Anemia--chemically induced Antineoplastic Agents--adverse effects Disease-Free Survival Everolimus--adverse effects Exanthema--chemically induced Female Humans Male Middle Aged Neoplasm Grading Neoplasm Recurrence, Local Pancreatic Neoplasms--drug therapy Prognosis Republic of Korea Retrospective Studies Stomatitis--chemically induced Treatment Outcome Young Adult